NYSE: NXENexgen Energy Ltd Stock
$6.87+0.15 (+2.23%)
Updated Jan 17, 2025
NXE Price
$6.87
Fair Value Price
N/A
Market Cap
$3.88B
52 Week Low
$4.95
52 Week High
$8.96
P/E
31.66x
P/B
4.41x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$100.79M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.39
Operating Cash Flow
-$27M
Beta
1.34
Next Earnings
Mar 5, 2025
Ex-Dividend
N/A
Next Dividend
N/A
NXE Overview
NexGen Energy Ltd. engages in the acquisition, exploration, and development of uranium properties. The company is headquartered in Vancouver, British Columbia and currently employs 32 full-time employees. The firm owns a portfolio of prospective uranium exploration assets in the Athabasca Basin, Saskatchewan, Canada, including a interest in Rook I, location of the Arrow Deposit, the Bow discovery, the Harpoon discovery and the Arrow South.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NXE's potential to beat the market
- NXE doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
Value
N/A
Growth
N/A
Momentum
N/A
Sentiment
N/A
Safety
N/A
Financials
N/A
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Uranium
Industry Rating
F
NXE
RankedUnranked of 3
RankedUnranked of 3
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.08 | D | |
| $77.83 | F | |
| $2.32 | F |
Be the first to know about important NXE news, forecast changes, insider trades & much more!
NXE News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NXE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NXE is poor value based on its earnings relative to its share price (31.66x), compared to the US market average (30.45x)
P/E vs Market Valuation
NXE is good value based on its earnings relative to its share price (31.66x), compared to the US Uranium industry average (48.56x)
P/E vs Industry Valuation
NXE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more NXE due diligence checks available for Premium users.
Valuation
NXE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
31.66x
Industry
48.56x
Market
30.45x
NXE is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NXE is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
NXE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.41x
Industry
4.39x
NXE is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NXE's financial health
Profit margin
Revenue
$0.0
Net Income
$7.5M
Profit Margin
0%
NXE's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$1.2B
Liabilities
$344.7M
Debt to equity
0.39
NXE's short-term assets ($394.72M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NXE's short-term assets ($394.72M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NXE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NXE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$2.1M
Investing
-$23.6M
Financing
$777.9k
NXE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
NXE vs Uranium Stocks
Nexgen Energy Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.